Advances in understanding and managing Scedosporium respiratory infections in patients with cystic fibrosis

References

• Hamutcu R, Rowland JM, Horn MV, et al. Clinical findings and lung pathology in children with cystic fibrosis. Am J Respir Crit Care Med. 2002;165:1172–1175.
   PubMed Web of Science ®Google Scholar
• Morrissey BM, Schock BC, Marelich GP, et al. Cystic fibrosis in adults: current and future management strategies. Clin Rev Allergy Immunol. 2003;25:275–287.
   PubMed Web of Science ®Google Scholar
• Castellani C, Assael BM. Cystic fibrosis: a clinical view. Cell Mol Life Sci. 2017;74:129–140.
   PubMed Web of Science ®Google Scholar
• Riordan JR. CFTR function and prospects for therapy. Annu Rev Biochem. 2008;77:701–726.
   PubMed Web of Science ®Google Scholar
• Moran O. The biophysics, biochemistry and physiology of CFTR. Cell Mol Life Sci. 2017;74:1–2.
   PubMed Web of Science ®Google Scholar
• George AM, Jones PM, Middleton PG. Cystic fibrosis infections: treatment strategies and prospects. FEMS Microbiol Lett. 2009;300:153–164.
   PubMed Web of Science ®Google Scholar
• Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med. 2011;183:1463–1471.
   PubMed Web of Science ®Google Scholar
• Langan KM, Kotsimbos T, Peleg AY. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis. Curr Opin Infect Dis. 2015;28:547–556.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Vandeputte P, Rougeron A, et al. and the ECMM/ISHAM working group Fungal respiratory infections in Cystic Fibrosis (Fri-CF). Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis. Med Mycol. 2018;56(Suppl. 1):46–59.
   Google Scholar
• Ramirez-Garcia A, Pellon A, Rementeria A, et al. Scedosporium and Lomentospora: an updated overview of underrated opportunists. Med Mycol. 2018;56(Suppl. 1):102–125.
   PubMedGoogle Scholar
• Zouhair R, Defontaine A, Ollivier C, et al. Typing of Scedosporium apiospermum by multilocus enzyme electrophoresis and random amplification of polymorphic DNA. J Med Microbiol. 2001;50:925–932.
   PubMed Web of Science ®Google Scholar
• Defontaine A, Zouhair R, Cimon B, et al. Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis. J Clin Microbiol. 2002;40:2108–2114.
   PubMed Web of Science ®Google Scholar
• Rainer J, de Hoog GS, Wedde M, et al. Molecular variability of Pseudallescheria boydii, a neurotropic opportunist. J Clin Microbiol. 2000;38(9):3267–3273.
   PubMed Web of Science ®Google Scholar
• Gilgado F, Cano J, Gené J, et al. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol. 2005;43:4930–4942.
   PubMed Web of Science ®Google Scholar
• Gilgado F, Cano J, Gené J, et al. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol. 2008;46:766–771.
   PubMed Web of Science ®Google Scholar
• Gilgado F, Gené J, Cano J, et al. Heterothallism in Scedosporium apiospermum and description of its teleomorph Pseudallescheria apiosperma sp. nov. Med Mycol. 2010;48:122–128.
   PubMed Web of Science ®Google Scholar
• Hawksworth DL, Crous PW, Redhead SA, et al. The Amsterdam declaration on fungal nomenclature. IMA Fungus. 2011;2:105–112.
   PubMed Web of Science ®Google Scholar
• Lackner M, de Hoog SG, Yang L, et al. Proposed nomenclature for Pseudallescheria, Scedosporium and related genera. Fungal Divers. 2014;67(1):1–10.
   Web of Science ®Google Scholar
• Crous PW, Wingfield MJ, Burgess TI, et al. Fungal Planet description sheets: 469–557. Persoonia. 2016;37:218–403.
   PubMed Web of Science ®Google Scholar
• Cimon B, Carrère J, Vinatier JF, et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2000;19:53–56.
   PubMed Web of Science ®Google Scholar
• Horré R, Marklein G, Siekmeier R, et al. Selective isolation of Pseudallescheria and Scedosporium species from respiratory tract specimens of cystic fibrosis patients. Respiration. 2009;77:320–324.
   PubMed Web of Science ®Google Scholar
• Sedlacek L, Graf B, Schwarz C, et al. Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium. J Cyst Fibros. 2015;14:237–241.
   PubMed Web of Science ®Google Scholar
• Ziesing S, Suerbaum S, Sedlacek L. Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center. Med Mycol. 2016;54(8):781–786.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Brandt C, Antweiler E, et al. Prospective multicenter German study on pulmonary colonization with Scedosporium/Lomentospora species in cystic fibrosis: epidemiology and new association factors. PLoS One. 2017;12(2):e0171485.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Brandt C, Melichar V, et al. Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis. J Cyst Fibros. 2019;18(2):227–232.
   PubMed Web of Science ®Google Scholar
• Masoud-Landgraf L, Badura A, Eber E, et al. Modified culture method detects a high diversity of fungal species in cystic fibrosis patients. Med Mycol. 2014;52(2):179–186.
   PubMed Web of Science ®Google Scholar
• Blyth CC, Middleton PG, Harun A, et al. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors? Med Mycol. 2010;48(Suppl 1):S37–44.
   PubMed Web of Science ®Google Scholar
• Zouhair R, Rougeron A, Razafimandimby B, et al. Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis. Med Mycol. 2013;51:603–613.
   PubMed Web of Science ®Google Scholar
• Amin R, Dupuis A, Aaron SD, et al. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest. 2010;137:171–176.
   PubMed Web of Science ®Google Scholar
• Fillaux J, Brémont F, Murris M, et al. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scand J Infect Dis. 2012;44:842–847.
   PubMed Web of Science ®Google Scholar
• Hong G, Alby K, Ng SCW, et al. The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis. J Cyst Fibros. 2019 Aug 21;pii: S1569–1993(19):30840–30849.
   Google Scholar
• Russell GK, Gadhok R, Simmonds NJ. The destructive combination of Scedosporium apiospermum lung disease and exuberant inflammation in cystic fibrosis. Ped Respir Rev. 2013;14:22–25.
   PubMed Web of Science ®Google Scholar
• Borghi E, Iatta R, Manca A, et al. Chronic airway colonization by Scedosporium apiospermum with fatal outcome in a patient with cystic fibrosis. Med Mycol. 2010;48(Suppl 1):S108–13.
   PubMedGoogle Scholar
• Guignard S, Hubert D, Dupont B, et al. Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient. J Cyst Fibros. 2008;7:89–91.
   PubMed Web of Science ®Google Scholar
• Morin O, Haloun A, Treilhaud M, et al. Mycose systémique à Pseudallescheria boydii chez une patiente greffée bipulmonaire pour une mucoviscidose. Etude des souches isolées en RAPD. J Mycol Méd. 1999;9:119–123.
   Google Scholar
• Castiglioni B, Sutton DA, Rinaldi MG, et al. Pseudallescheria boydii (anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002;81:333–348.
   PubMed Web of Science ®Google Scholar
• Symoens F, Knoop C, Schrooyen M, et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant. 2006;25:603–607.
   PubMed Web of Science ®Google Scholar
• Morio F, Horeau-Langlard D, Gay-Andrieu F, et al. Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol. 2010;48:1978–1982.
   PubMed Web of Science ®Google Scholar
• Luijk B, Ekkelenkamp MB, De Jong PA, et al. Effective prolonged therapy with voriconazole in a lung transplant recipient with spondylodiscitis induced by Scedosporium apiospermum. Case Rep Infect Dis. 2011;2011:460313.
   PubMedGoogle Scholar
• Hirschi S, Letscher-Bru V, Pottecher J, et al. Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient. J Clin Microbiol. 2012;50:4168–4170.
   PubMed Web of Science ®Google Scholar
• Miraldi F, Anile M, Ruberto F, et al. Scedosporium apiospermum atrial mycetomas after lung transplantation for cystic fibrosis. Transpl Infect Dis. 2012;14:188–191.
   PubMed Web of Science ®Google Scholar
• Rolfe NE, Haddad TJ, Wills TS. Management of Scedosporium apiospermum in a pre- and post-lung transplant patient with cystic fibrosis. Med Mycol. 2013;2:37–39.
   Google Scholar
• Hartmann C, Müller C, Weißbrodt H, et al. Successful prevention of scedosporiosis after lung transplantation in a cystic fibrosis patient by combined local and systemic triazole therapy. Med Mycol Case Rep. 2013;2:116–118.
   PubMedGoogle Scholar
• Doligalski CT, Benedict K, Cleveland AA, et al. Epidemiology of invasive mold infections in lung transplant recipients. Am J Transplant. 2014;14(6):1328–1333.
   PubMed Web of Science ®Google Scholar
• Solé A, García-Robles AA, Jordá C, et al. Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection. Am J Transplant. 2018;18(2):504–509.
   PubMed Web of Science ®Google Scholar
• Rougeron A, Giraud S, Alastruey-Izquierdo A, et al. Ecology of Scedosporium species: present knowledge and future research. Mycopathologia. 2018;183(1):185–200.
   PubMed Web of Science ®Google Scholar
• Rainer J, Kaltseis J, de Hoog SG, et al. Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex. Antonie Van Leeuwenhoek. 2008;93:315–322.
   PubMed Web of Science ®Google Scholar
• Pham T, Giraud S, Schuliar G, et al. Scedo-select III: a new semi-selective culture medium for detection of the Scedosporium apiospermum species complex. Med Mycol. 2015;53(5):512–519.
   PubMed Web of Science ®Google Scholar
• Kaltseis J, Rainer J, de Hoog GS. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol. 2009;47:398–405.
   PubMed Web of Science ®Google Scholar
• Rougeron A, Schuliar G, Leto J, et al. Human-impacted areas of France are environmental reservoirs of the Pseudallescheria boydii/Scedosporium apiospermum species complex. Environ Microbiol. 2015;17(4):1039–1048.
   PubMed Web of Science ®Google Scholar
• Elizondo-Zertuche M, Treviño-Rangel R DJ, Robledo-Leal E, et al. Molecular identification and in vitro antifungal susceptibility of Scedosporium complex isolates from high-human-activity sites in Mexico. Mycologia. 2017;109(6):874–881.
   PubMed Web of Science ®Google Scholar
• Luplertlop N, Pumeesat P, Muangkaew W, et al. Environmental screening for the Scedosporium apiospermum species complex in public parks in Bangkok, Thailand. PLoS One. 2016;11(7):e0159869.
   PubMed Web of Science ®Google Scholar
• Luplertlop N, Muangkaew W, Pumeesat P, et al. Distribution of Scedosporium species in soil from areas with high human population density and tourist popularity in six geographic regions in Thailand. PLoS One. 2019;14(1):e0210942.
   PubMed Web of Science ®Google Scholar
• Harun A, Gilgado F, Chen SC, et al. Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis. Med Mycol. 2010;48(Suppl 1):S70–6.
   PubMedGoogle Scholar
• Alvarez E, Sanhueza C. New record of Scedosporium dehoogii from Chile: phylogeny and susceptibility profiles to classic and novel putative antifungal agents. Rev Iberoam Micol. 2016;33(4):224–229.
   PubMed Web of Science ®Google Scholar
• Beguin H, Nolard N. Mould diversity in homes. Air and surface analysis of 130 dwellings. Aerobiologica. 1994;10:157–166.
   Google Scholar
• Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia. 1989;106:13–22.
   PubMed Web of Science ®Google Scholar
• Sidot C, Cimon B, Bouchara JP, et al. Scedosporium apiospermum. Environmental study in the homes of patients with cystic fibrosis. J Cyst Fibros. 2007;6(Suppl 1):S29.
   Google Scholar
• Ceylan E, Ozkutuk A, Ergor G, et al. Fungi and indoor conditions in asthma patients. J Asthma. 2006;43:789–794.
   PubMed Web of Science ®Google Scholar
• Araujo R, Cabral JP, Rodrigues AG. Air filtration systems and restrictive access conditions improve indoor air quality in clinical units: Penicillium as a general indicator of hospital indoor fungal levels. Am J Infect Control. 2008;36:129–134.
   PubMed Web of Science ®Google Scholar
• Saldanha R, Manno M, Saleh M, et al. The influence of sampling duration on recovery of culturable fungi using the Andersen N6 and RCS bioaerosol samplers. Indoor Air. 2008;18:464–472.
   PubMed Web of Science ®Google Scholar
• Ramos CA, Viegas C, Verde SC, et al. Characterizing the fungal and bacterial microflora and concentrations in fitness centres. Indoor Built Environ. 2016;25:872–882.
   Web of Science ®Google Scholar
• Pinto MR, Mulloy B, Haido RM, et al. A peptidorhamnomannan from the mycelium of Pseudallescheria boydii is a potential diagnostic antigen of this emerging human pathogen. Microbiology. 2001;147:1499–1506.
   PubMed Web of Science ®Google Scholar
• Pinto MR, de Sá AC, Limongi CL, et al. Involvement of peptidorhamnomannan in the interaction of Pseudallescheria boydii and HEp2 cells. Microbes Infect. 2004;6:1259–1267.
   PubMed Web of Science ®Google Scholar
• Bittencourt VC, Figueiredo RT, da Silva RB, et al. An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and toll-like receptor activation. J Biol Chem. 2006;281:22614–22623.
   PubMed Web of Science ®Google Scholar
• Figueiredo RT, Bittencourt VC, Lopes LC, et al. Toll-like receptors (TLR2 and TLR4) recognize polysaccharides of Pseudallescheria boydii cell wall. Carbohydr Res. 2012;356:260–264.
   PubMed Web of Science ®Google Scholar
• Pinto MR, Rodrigues ML, Travassos LR, et al. Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation. Glycobiology. 2002;12:251–260.
   PubMed Web of Science ®Google Scholar
• Ghamrawi S, Gastebois A, Zykwinska A, et al. A multifaceted study of Scedosporium boydii cell wall changes during germination and identification of GPI-anchored proteins. PLoS One. 2015;10(6):e0128680.
   PubMed Web of Science ®Google Scholar
• Ghamrawi S, Renier G, Saulnier P, et al. Cell wall modifications during maturation of conidia in the human pathogenic fungus, Pseudallescheria boydii. PLoS One. 2014;9:e100290.
   PubMed Web of Science ®Google Scholar
• Heinekamp T, Thywißen A, Macheleidt J, et al. Aspergillus fumigatus melanins: interference with the host endocytosis pathway and impact on virulence. Front Microbiol. 2013;3:440.
   PubMed Web of Science ®Google Scholar
• Aimanianda V, Latgé JP. Fungal hydrophobins form a sheath preventing immune recognition of airborne conidia. Virulence. 2010;1:185–187.
   PubMed Web of Science ®Google Scholar
• da Silva BA, Dos Santos AL, Barreto-Bergter E, et al. Extracellular peptidase in the fungal pathogen Pseudallescheria boydii. Curr Microbiol. 2006;53:18–22.
   PubMed Web of Science ®Google Scholar
• Larcher G, Cimon B, Symoens F, et al. A 33-kDa serine proteinase from Scedosporium apiospermum. Biochem J. 1996;315:119–126.
   PubMed Web of Science ®Google Scholar
• Lima OC, Larcher G, Vandeputte P, et al. Molecular cloning and biochemical characterization of a Cu,Zn-superoxide dismutase from Scedosporium apiospermum. Microbes Infect. 2007;9:558–565.
   PubMed Web of Science ®Google Scholar
• Mina S, Marot-Leblond A, Cimon B, et al. Purification and characterization of a mycelial catalase from Scedosporium boydii: a useful tool for specific antibody detection in patients with cystic fibrosis. Clin Vaccine Immunol. 2015;22:37–45.
   PubMedGoogle Scholar
• Kiffer-Moreira T, Pinheiro AA, Pinto MR, et al. Mycelial forms of Pseudallescheria boydii present ectophosphatase activities. Arch Microbiol. 2007;188:159–166.
   PubMed Web of Science ®Google Scholar
• Mina S, Staerck C, d’Almeida SM, et al. Identification of Scedosporium boydii catalase A1 gene, a reactive oxygen species detoxification factor highly expressed in response to oxidative stress and phagocytic cells. Fungal Biol. 2015;119(12):1322–1333.
   PubMed Web of Science ®Google Scholar
• Bertrand S, Larcher G, Landreau A, et al. Hydroxamate siderophores of Scedosporium apiospermum. Biometals. 2009;22:1019–1029.
   PubMed Web of Science ®Google Scholar
• Bertrand S, Bouchara JP, Venier MC, et al. N(α)-methyl coprogen B, a potential marker of the airway colonization by Scedosporium apiospermum in patients with cystic fibrosis. Med Mycol. 2010;48(Suppl 1):S98–107.
   PubMedGoogle Scholar
• Vandeputte P, Ghamrawi S, Rechenmann M, et al. Draft genome sequence of the pathogenic fungus Scedosporium apiospermum. Genome Announc. 2014;2(5):pii: e00988–14.
   PubMedGoogle Scholar
• Pérez-Bercoff Å, Papanicolau A, Ramsperger M, et al. Draft genome of the opportunistic human pathogen Scedosporium aurantiacum – Australian environmental strain WM 09.24.. Genome Announc. 2015;3(1):pii: e01526–14.
   PubMedGoogle Scholar
• Morales LT, González-García LN, Orozco MC, et al. The genomic study of an environmental isolate of Scedosporium apiospermum shows its metabolic potential to degrade hydrocarbons. Stand Genomic Sci. 2017;12:71.
   PubMed Web of Science ®Google Scholar
• Duvaux L, Shiller J, Vandeputte P, et al. Draft genome sequence of the human-pathogenic fungus Scedosporium boydii. Genome Announc. 2017;5(37):pii: e00871–17.
   PubMedGoogle Scholar
• Pateau V, Razafimandimby B, Vandeputte P, et al. Gene disruption in Scedosporium aurantiacum: proof of concept with the disruption of SODC gene encoding a cytosolic Cu,Zn-superoxide dismutase. Mycopathologia. 2018;183(1):241–249.
   PubMed Web of Science ®Google Scholar
• Ramirez-Garcia A, Pellon A, Buldain I, et al. Proteomics as a tool to identify new targets against Aspergillus and Scedosporium in the context of cystic fibrosis. Mycopathologia. 2018;183(1):273–289.
   PubMed Web of Science ®Google Scholar
• Staerck C, Tabiasco J, Godon C, et al. Transcriptional profiling of Scedosporium apiospermum enzymatic antioxidant gene battery unravels the involvement of thioredoxin reductases against chemical and phagocytic cells oxidative stress. Med Mycol. 2019;57(3):363–373.
   PubMed Web of Science ®Google Scholar
• Le Govic Y, Papon N, Le Gal S, et al. Non-ribosomal peptide synthetase gene clusters in the human pathogenic fungus Scedosporium apiospermum. Front Microbiol. 2019;10:2062.
   PubMed Web of Science ®Google Scholar
• Pavlaskova K, Nedved J, Kuzma M, et al. Characterization of pseudacyclins A-E, a suite of cyclic peptides produced by Pseudallescheria boydii. J Nat Prod. 2010;73:1027–1032.
   PubMed Web of Science ®Google Scholar
• Wu Q, Jiang N, Bo Han W, et al. Antibacterial epipolythiodioxopiperazine and unprecedented sesquiterpene from Pseudallescheria boydii, a beetle (coleoptera)-associated fungus. Org Biomol Chem. 2014;12:9405–9412.
   PubMed Web of Science ®Google Scholar
• Lan WJ, Wang KT, Xu MY, et al. Secondary metabolites with chemical diversity from the marine-derived fungus Pseudallescheria boydii F19–1 and their cytotoxic activity. RSC Adv. 2016;6:76206–76213.
   Web of Science ®Google Scholar
• Li X, Kim SK, Nam KW, et al. A new antibacterial dioxopiperazine alkaloid related to gliotoxin from a marine isolate of the fungus Pseudallescheria. J Antibiot (Tokyo). 2006;59(4):248–250.
   PubMed Web of Science ®Google Scholar
• Scharf DH, Heinekamp T, Remme N, et al. Biosynthesis and function of gliotoxin in Aspergillus fumigatus. Appl Microbiol Biotechnol. 2012;93(2):467–472.
   PubMed Web of Science ®Google Scholar
• Le Govic Y, Papon N, Le Gal S, et al. Genomic organization and expression of iron metabolism genes in the emerging pathogenic mold Scedosporium apiospermum. Front Microbiol. 2018;9:827.
   PubMed Web of Science ®Google Scholar
• Staerck C, Landreau A, Herbette G, et al. The secreted polyketide boydone A is responsible for the anti-Staphylococcus aureus activity of Scedosporium boydii. FEMS Microbiol Lett. 2017;364:22.
   Web of Science ®Google Scholar
• Hong G, Lechtzin N, Hadjiliadis D, et al. Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis. Pediatr Pulmonol. 2019;54(2):133–140.
   PubMed Web of Science ®Google Scholar
• Chen SC, Patel S, Meyer W, et al. Pseudomonas aeruginosa inhibits the growth of Scedosporium and Lomentospora in vitro. Mycopathologia. 2018;183(1):251–261.
   PubMed Web of Science ®Google Scholar
• Borman AM, Palmer MD, Delhaes L, et al. Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. Med Mycol. 2010;48(Suppl 1):S88–97.
   PubMedGoogle Scholar
• Boyle M, Moore JE, Whitehouse JL, et al. Laboratory diagnosis and characterization of fungal disease in patients with cystic fibrosis (CF): a survey of current UK practice in a cohort of clinical microbiology laboratories. Mycopathologia. 2018;183(4):723–729.
   PubMed Web of Science ®Google Scholar
• Chen SC, Meyer W, Pashley CH. Challenges in laboratory detection of fungal pathogens in the airways of cystic fibrosis patients. Mycopathologia. 2018;183(1):89–100.
   PubMed Web of Science ®Google Scholar
• Boyle M, Moore JE, Whitehouse JL, et al. The diagnosis and management of respiratory tract fungal infection in cystic fibrosis: a UK survey of current practice. Med Mycol. 2019;57(2):155–160.
   PubMed Web of Science ®Google Scholar
• Hong G, Miller HB, Allgood S, et al. Use of selective fungal culture media increases rates of detection of fungi in the respiratory tract of cystic fibrosis patients. J Clin Microbiol. 2017;55(4):1122–1130.
   PubMed Web of Science ®Google Scholar
• Nagano Y, Millar BC, Goldsmith CE, et al. Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF). J Cyst Fibros. 2008;7(6):566–572.
   PubMed Web of Science ®Google Scholar
• Coron N, Pihet M, Fréalle E, et al. Toward the standardization of mycological examination of sputum samples in cystic fibrosis: results from a French multicenter prospective study. Mycopathologia. 2018;183(1):101–117.
   PubMed Web of Science ®Google Scholar
• Delhaes L, Touati K, Faure-Cognet O, et al. Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: results from the international prospective study “MFIP”. J Cyst Fibros. 2019;18(2):212–220.
   PubMed Web of Science ®Google Scholar
• Lu Q, Gerrits van den Ende AH, Bakkers JM, et al. Identification of Pseudallescheria and Scedosporium species by three molecular methods. J Clin Microbiol. 2011;49:960–967.
   PubMed Web of Science ®Google Scholar
• Lackner M, Najafzadeh MJ, Sun J, et al. Rapid identification of Pseudallescheria and Scedosporium strains by using rolling circle amplification. Appl Environ Microbiol. 2012;78:126–133.
   PubMed Web of Science ®Google Scholar
• Lackner M, Klaassen CH, Meis JF, et al. Molecular identification tools for sibling species of Scedosporium and Pseudallescheria. Med Mycol. 2012;50:497–508.
   PubMed Web of Science ®Google Scholar
• Sitterlé E, Giraud S, Léto J, et al. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry for fast and accurate identification of Pseudallescheria/Scedosporium species. Clin Microbiol Infect. 2014;20:929–935.
   PubMed Web of Science ®Google Scholar
• Lu Q, van den Ende AH, de Hoog GS, et al. Reverse line blot hybridisation screening of Pseudallescheria/Scedosporium species in patients with cystic fibrosis. Mycoses. 2011;54(Suppl 3):5–11.
   PubMedGoogle Scholar
• Chen M, Kondori N, Deng S, et al. Direct detection of Exophiala and Scedosporium species in sputa of patients with cystic fibrosis. Med Mycol. 2018;56(6):695–702.
   PubMed Web of Science ®Google Scholar
• Bouchara JP, Hsieh HY, Croquefer S, et al. Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis. J Clin Microbiol. 2009;47:142–152.
   PubMed Web of Science ®Google Scholar
• Spiess B, Seifarth W, Hummel M, et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol. 2007;45:3743–3753.
   PubMed Web of Science ®Google Scholar
• Lau A, Sorrell TC, Chen S, et al. Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol. 2008;46:3021–3027.
   PubMed Web of Science ®Google Scholar
• Wolk DM, Kaleta EJ, Wysocki VH. PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn. 2012;14:295–304.
   PubMed Web of Science ®Google Scholar
• Shin JH, Ranken R, Sefers SE, et al. Detection, identification, and distribution of fungi in bronchoalveolar lavage specimens by use of multilocus PCR coupled with electrospray ionization/mass spectrometry. J Clin Microbiol. 2013;51:136–141.
   PubMed Web of Science ®Google Scholar
• Simner PJ, Uhl JR, Hall L, et al. Broad-range direct detection and identification of fungi by use of the PLEX-ID PCR-electrospray ionization mass spectrometry (ESI-MS) system. J Clin Microbiol. 2013;51:1699–1706.
   PubMed Web of Science ®Google Scholar
• Hong G, White M, Lechtzin N, et al. Fatal disseminated Rasamsonia infection in cystic fibrosis post-lung transplantation. J Cyst Fibros. 2017;16(2):e3–7.
   PubMedGoogle Scholar
• Harun A, Perdomo H, Gilgado F, et al. Genotyping of Scedosporium species: a review of molecular approaches. Med Mycol. 2009;47:406–414.
   PubMed Web of Science ®Google Scholar
• Delhaes L, Harun A, Chen SC, et al. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg Infect Dis. 2008;14:282–290.
   PubMed Web of Science ®Google Scholar
• Bernhardt A, Sedlacek L, Wagner S, et al. Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients. J Cyst Fibros. 2013;12:592–598.
   PubMed Web of Science ®Google Scholar
• Matray O, Mouhajir A, Giraud S, et al. Semi-automated repetitive sequence-based PCR amplification for species of the Scedosporium apiospermum complex. Med Mycol. 2016;54(4):409–419.
   PubMed Web of Science ®Google Scholar
• Mina S, Staerck C, Marot A, et al. Scedosporium boydii CatA1 and SODC recombinant proteins, new tools for serodiagnosis of Scedosporium infection of patients with cystic fibrosis. Diagn Microbiol Infect Dis. 2017;89(4):282–287.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Ruiz-Díez B, Martínez-Suárez JV, et al. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother. 1999;43:149–151.
   PubMed Web of Science ®Google Scholar
• Carrillo AJ, Guarro J. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother. 2001;45:2151–2153.
   PubMed Web of Science ®Google Scholar
• Meletiadis J, Meis JF, Mouton JW, et al. EUROFUNG Network. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother. 2002;46:62–68.
   PubMed Web of Science ®Google Scholar
• Gilgado F, Serena C, Cano J, et al. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother. 2006;50:4211–4213.
   PubMed Web of Science ®Google Scholar
• Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, et al. Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates. Antimicrob Agents Chemother. 2007;51:748–751.
   PubMed Web of Science ®Google Scholar
• Lackner M, de Hoog GS, Verweij PE, et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother. 2012;56:2635–2642.
   PubMed Web of Science ®Google Scholar
• Chabasse D, Bouchara JP, Chazalette JP, et al. Mucoviscidose et colonisation fongique à Scedosporium apiospermum. A propos de trois observations. J Mycol Méd. 1991;1:152–155.
   Google Scholar
• Lelièvre B, Legras P, Godon C, et al. Experimental models of disseminated scedosporiosis with cerebral involvement. J Pharmacol Exp Ther. 2013;345:198–205.
   PubMed Web of Science ®Google Scholar
• Rodríguez MM, Pastor FJ, Salas V, et al. Experimental murine scedosporiosis: histopathology and azole treatment. Antimicrob Agents Chemother. 2010;54:3980–3984.
   PubMed Web of Science ®Google Scholar
• Lackner M, Rezusta A, Villuendas MC, et al. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates. Mycoses. 2011;54(Suppl 3):12–21.
   PubMedGoogle Scholar
• Johnson ME, Katiyar SK, Edlind TD. New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species. Antimicrob Agents Chemother. 2011;55:3774–3781.
   PubMed Web of Science ®Google Scholar
• Trovato L, Scalia G, Palermo CI, et al. Evaluation of isavuconazole MIC strips for susceptibility testing of Aspergillus and Scedosporium species. Med Mycol. 2019;57(4):429–433.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Richardson M, Roilides E, et al. European society of clinical microbiology and infectious diseases fungal infection study group; European confederation of medical mycology. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;20(Suppl 3):27–46.
   PubMed Web of Science ®Google Scholar
• Martin-Vicente A, Guarro J, González GM, et al. Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis. J Antimicrob Chemother. 2017;72(4):1118–1122.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L, et al. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother. 2008;52:1136–1139.
   PubMed Web of Science ®Google Scholar
• Lamoth F, Alexander BD. Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates. Antimicrob Agents Chemother. 2015;59(7):4308–4311.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Horii T, Hata K, et al. In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds. Antimicrob Agents Chemother. 2011;55:4652–4658.
   PubMed Web of Science ®Google Scholar
• Castanheira M, Duncanson FP, Diekema DJ, et al. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrob Agents Chemother. 2012;56:352–357.
   PubMed Web of Science ®Google Scholar
• Hata K, Horii T, Miyazaki M, et al. Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis. Antimicrob Agents Chemother. 2011;55:4543–4551.
   PubMed Web of Science ®Google Scholar
• Wiederhold NP, Najvar LK, Shaw KJ, et al. Efficacy of delayed therapy with Fosmanogepix (APX001) in a murine model of Candida auris invasive candidiasis. Antimicrob Agents Chemother. 2019;63(11):pii: e01120–19.
   Web of Science ®Google Scholar
• Alkhazraji S, Gebremariam T, Alqarihi A, et al. Fosmanogepix (APX001) is effective in the treatment of immunocompromised mice infected with invasive pulmonary scedosporiosis or disseminated fusariosis. Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.01735-19.
   Google Scholar
• Oliver JD, Sibley GEM, Beckmann N, et al. F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc Natl Acad Sci U S A. 2016;113:12809–12814.
   PubMed Web of Science ®Google Scholar
• Wiederhold NP, Law D, Birch M. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans. J Antimicrob Chemother. 2017;72(7):1977–1980.
   PubMed Web of Science ®Google Scholar
• Biswas C, Law D, Birch M, et al. In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi. Med Mycol. 2018;56(8):1050–1054.
   PubMed Web of Science ®Google Scholar
• Nagl M, Arnitz R, Lackner M. N-Chlorotaurine, a promising future candidate for topical therapy of fungal infections. Mycopathologia. 2018;183(1):161–170.
   PubMed Web of Science ®Google Scholar
• Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3(8):673–683.
   PubMed Web of Science ®Google Scholar
• Wiederhold NP, Patterson TF, Srinivasan A, et al. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi. Virulence. 2017;8(2):138–142.
   PubMed Web of Science ®Google Scholar
• Fuchs BB, RajaMuthiah R, Souza AC, et al. Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin. Future Med Chem. 2016;8(2):117–132.
   PubMed Web of Science ®Google Scholar